Table 2 Re-stratification matrix of the number of MDS patients classified in each of the WHO 2016 classification (column) and each of the WHO 2022 classification (row).
WHO-2016, n | MDS-5q | MDS-RS-SLD | MDS-RS-MLD | MDS-SLD | MDS-MLD | MDS-EB1 | MDS-EB2 | MDS-U | Number of patients, n (%) |
|---|---|---|---|---|---|---|---|---|---|
WHO-2022, n | |||||||||
MDS-5q | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11(1.3) |
MDS-SF3B1 | 0 | 21 | 24 | 3 | 21 | 0 | 0 | 1 | 70 (8.6) |
MDS-biTP53 | 1 | 1 | 0 | 1 | 14 | 10 | 24 | 2 | 53 (6.5) |
MDS-LB | 0 | 0 | 0 | 34 | 254 | 0 | 0 | 5 | 293 (36) |
MDS-h | 0 | 0 | 0 | 11 | 67 | 0 | 0 | 2 | 80 (9.8) |
MDS-IB1 | 0 | 0 | 0 | 0 | 0 | 161 | 0 | 0 | 161 (19.8) |
MDS-IB2 | 0 | 0 | 0 | 0 | 0 | 0 | 103 | 0 | 103 (12.7) |
MDS-f | 0 | 0 | 0 | 0 | 0 | 20 | 22 | 0 | 42 (5.2) |
Number of patients, n (%) | 12 (1.5) | 22 (2.7) | 24 (3.0) | 49 (6) | 356 (43.8) | 191 (23.5) | 149 (18.3) | 10 (1.2) | 813 |
